AU1408999A - Detection and treatment of retinal degenerative disease - Google Patents

Detection and treatment of retinal degenerative disease

Info

Publication number
AU1408999A
AU1408999A AU14089/99A AU1408999A AU1408999A AU 1408999 A AU1408999 A AU 1408999A AU 14089/99 A AU14089/99 A AU 14089/99A AU 1408999 A AU1408999 A AU 1408999A AU 1408999 A AU1408999 A AU 1408999A
Authority
AU
Australia
Prior art keywords
detection
treatment
degenerative disease
retinal degenerative
retinal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU14089/99A
Inventor
Constance L. Cepko
Carol L. Freund
Takahisa Furukawa
Jens Looser
Roderick R. McInnes
Eric M. Morrow
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Hospital for Sick Children HSC
Harvard College
Original Assignee
Hospital for Sick Children HSC
Harvard College
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hospital for Sick Children HSC, Harvard College filed Critical Hospital for Sick Children HSC
Publication of AU1408999A publication Critical patent/AU1408999A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/156—Polymorphic or mutational markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2600/00—Oligonucleotides characterized by their use
    • C12Q2600/158—Expression markers

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Pathology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
AU14089/99A 1997-11-13 1998-11-13 Detection and treatment of retinal degenerative disease Abandoned AU1408999A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US6532197P 1997-11-13 1997-11-13
US60065321 1997-11-13
PCT/US1998/024322 WO1999025721A1 (en) 1997-11-13 1998-11-13 Detection and treatment of retinal degenerative disease

Publications (1)

Publication Number Publication Date
AU1408999A true AU1408999A (en) 1999-06-07

Family

ID=22061896

Family Applications (1)

Application Number Title Priority Date Filing Date
AU14089/99A Abandoned AU1408999A (en) 1997-11-13 1998-11-13 Detection and treatment of retinal degenerative disease

Country Status (2)

Country Link
AU (1) AU1408999A (en)
WO (1) WO1999025721A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030054446A1 (en) * 2000-11-29 2003-03-20 Weber Bernard H. F. Novel retina-specific human proteins C7orf9, C12orf7, MPP4 and F379
CA2514971C (en) 2003-02-03 2012-08-14 Japan Science And Technology Agency Regeneration and neogenesis of retinal photoreceptor cell using otx2 gene
GB2457300A (en) * 2008-02-08 2009-08-12 Norwegian School Of Veterinary Diagnosis of cone-rod dystrophy
WO2022021149A1 (en) * 2020-07-29 2022-02-03 北京中因科技有限公司 Gene editing therapy for aav-mediated rpgr x-linked retinal degeneration
WO2022217142A1 (en) * 2021-04-09 2022-10-13 Washington University Compositions and methods for treatment of crx-linked retinopathies

Also Published As

Publication number Publication date
WO1999025721A1 (en) 1999-05-27
WO1999025721B1 (en) 1999-07-22

Similar Documents

Publication Publication Date Title
AU2209697A (en) Fluorocarbons for diagnosis and treatment of articular disorders
AU3790399A (en) Blood set and chamber
AU7538398A (en) Emulsion for well and formation treatment
AUPP784398A0 (en) Kidney disease detection and treatment
AU1585999A (en) Methods for the detection and treatment of disease using a glycosyltransferase
AU7048596A (en) Grounded electrode medical implement and system
AU1645499A (en) Tissue sealing electrosurgery device and methods of sealing tissue
AU1372897A (en) 2-amino-heterocycles and therapeutic uses therefor
AU3656397A (en) Formulations of vesicant drugs and methods of use thereof
AU2463099A (en) Gabapentin and its derivatives for the treatment of muscular and skeletal pain
AU6435398A (en) Prevention and treatment of hepatocellular cancer
AU2749395A (en) Medical use of bromelain
AU2054797A (en) Isolated human herpesvirus type 8 sequences and uses thereof
AU1408999A (en) Detection and treatment of retinal degenerative disease
AU7529796A (en) S-nitroso-hemoglobin and therapeutic uses thereof
AU1456899A (en) Human protein kinase and kinase inhibitors
AU1181897A (en) Medical use of proteases
AU2913397A (en) Method and system for non-invasive determination of the main cardiorespiratory parameters of the human body
AU5984196A (en) Treatment and prevention of prostatic disease
AU4841296A (en) Diagnosis of and compositions and methods for the treatment of disease
AU5697996A (en) Peptidyl compounds and their therapeutic use
AU9797598A (en) Treatment of diabetic retinopathy
AU8760298A (en) Coup-tfi directed therapies in the treatment of disease
AU6404698A (en) Treatment methods for obtaining therapeutic products and resulting products
AU7259898A (en) Human smt-3 like protein

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase